Federal contract award

75N93020C00016

TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIAID
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$25.0M
Current contract value$25.0M
Potential contract value / ceiling$44.5M
Start dateJul 1, 2020
Current end dateJan 18, 2027
Potential end dateJan 18, 2027
Latest award activityJul 23, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 23, 2026P00014$0EO14398 - NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Jan 16, 2026P00013$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Jul 31, 2025P00012$255.9KNON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Nov 22, 2024P00011$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Sep 10, 2024P00010$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Aug 1, 2024P00009$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Jul 1, 2024P00008$9.4MNON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Aug 29, 2023P00007$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
May 16, 2023P00006$4.7MNON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Jan 9, 2023P00005$0NON BETA-LACTAM INHIBITORS OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Sep 16, 2022P00004$4.5MTO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
May 26, 2022P00003$3.0MTO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Dec 21, 2021P00002$0TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Sep 11, 2020P00001$0TO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.
Jun 29, 20200$3.2MTO ADVANCE A NOVEL BETA-LACTAMASE INHIBITOR OF PENICILLIN BINDING PROTEINS TARGETING MDR-ACINETOBACTER BAUMANNII.

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
80/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 80/100. Available recorded signals: 75 points.

Contract end 2027-01-18 (78 days from calculation)
+35 points
155 historical awards in this buyer and category group
+15 points
15 recorded award transactions
+10 points
Latest award action: 2026-07-23
+5 points
Parent award identifier recorded
+0 points
Solicitation identifier recorded
+10 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.